Daniel Jacoby, MD - Easing the Burden of Hypertrophic Cardiomyopathy: Progress in Understanding and Addressing Its Pathophysiology

Go online to PeerView.com/BQR860 to view the activity, download
slides and practice aids, and complete the post-test to earn
credit. In this activity, based on a recent live satellite
symposium held at HFSA 2021, expert faculty review the evidence for
current and emerging treatment strategies for hypertrophic
cardiomyopathy (HCM) using patient cases to illustrate the ways in
which clinicians can adapt current practices and utilize shared
decision-making to offer appropriate treatment options to patients
with HCM. Upon completion of this activity, participants should be
better able to: Recognize HCM’s pathophysiology and the associated
disease burdens that may be experienced by patients (eg, health
impact, quality of life, daily activities), Apply the latest
recommendations and guidance for diagnosing, evaluating, and
monitoring patients with HCM in a team-based manner, Evaluate
current and emerging strategies for managing HCM in terms of
efficacy, safety, and effects on burden of disease, Collaborate
with patients to identify their individual goals and counsel them
about the benefits and risks of testing and treatment.